Results 211 to 220 of about 106,261 (297)

Elevated serum aminotransferases in an infant with failure to thrive: A clinicopathological case report

open access: yes
JPGN Reports, Volume 7, Issue 2, Page 340-348, May 2026.
Jamie M. Klapp   +4 more
wiley   +1 more source

Bilateral intramural ectopic ureters, ureteroureteral fenestration, hydroureters, renal dysplasia and a unilateral ureterocele in a young Golden Retriever

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 4‐month‐old, intact female, Golden Retriever presented with lifelong urinary incontinence. Initial diagnostics revealed mild leukocytosis, regenerative anaemia, mild azotemia and bacteriuria with Escherichia coli. Abdominal computed tomography identified bilateral intramural ectopic ureters (EUs) with severe hydroureters, bilateral renal ...
Miruna Munteanu   +3 more
wiley   +1 more source

A mulberry in female hypertrophic cardiomyopathy. [PDF]

open access: yesOxf Med Case Reports
Imataki O   +3 more
europepmc   +1 more source

Integrative Use of Ningmitai Capsule and Cefoxitin in Treating Post‐Ureteroscopic Lithotripsy Stent‐Related Urinary Tract Infections

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
Clinical Value of Ningmitai Capsule Combined with Cefoxitin in the Management of UTI Following URL with Stent Placement Based on Logistic Regression and DCA. ABSTRACT Ureteral stent placement following ureteroscopic lithotripsy (URL) reduces obstruction but increases the risk of urinary tract infection (UTI).
Gang Chen, Jun Zhou
wiley   +1 more source

First‐In‐Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT‐02 Freebase, a CNS‐Penetrant NLRP3 Inhibitor

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT The NLRP3 inflammasome is a central mediator of innate immunity and a key driver of inflammatory and neurodegenerative diseases. VENT‐02 is orally bioavailable, central nervous system‐penetrant, selective small‐molecule inhibitor of NLRP3. This first‐in‐human, randomized, double‐blind, placebo‐controlled study assessed the safety, tolerability,
Lisanne C. A. Smidt   +14 more
wiley   +1 more source

Urinalysis and Standardization

open access: yesGomal Journal of Medical Sciences, 2004
Ali Marjan Khattak, Bushra Ashiq
doaj  

Comparison of SGLT2 Inhibitors for New‐Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4314-4325, May 2026.
ABSTRACT Aims To compare the effects of individual SGLT2 inhibitors on preventing new‐onset proteinuria in patients with type 2 diabetes and preserved kidney function. Materials and Methods A target trial emulation was performed using commercially available databases, including health checkups and claims data, between April 1, 2014 and March 31, 2023 ...
Hiroki Nobayashi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy